Patents by Inventor Allyson MAYER

Allyson MAYER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260061040
    Abstract: The present disclosure relates to compositions and methods of using the same for the treatment of various metabolic diseases and related disorders (e.g. diabetes mellitus, NAFLD, obesity, metabolic syndrome). The compositions and methods of the disclosure relate to the administration of an arginine-degrading enzyme.
    Type: Application
    Filed: November 6, 2025
    Publication date: March 5, 2026
    Inventors: Brian J. DEBOSCH, Cassandra HIGGINS, Yiming ZHANG, Allyson MAYER
  • Patent number: 12508306
    Abstract: The present disclosure relates to compositions and methods of using the same for the treatment of various metabolic diseases and related disorders (e.g. diabetes mellitus, NAFLD, obesity, metabolic syndrome). The compositions and methods of the disclosure relate to the administration of an arginine-degrading enzyme.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: December 30, 2025
    Assignee: Washington University
    Inventors: Brian J. Debosch, Cassandra Higgins, Yiming Zhang, Allyson Mayer
  • Publication number: 20210077598
    Abstract: The present disclosure relates to compositions and methods of using the same for the treatment of various metabolic diseases and related disorders (e.g. diabetes mellitus, NAFLD, obesity, metabolic syndrome). The compositions and methods of the disclosure relate to the administration of an arginine-degrading enzyme.
    Type: Application
    Filed: April 25, 2019
    Publication date: March 18, 2021
    Inventors: Brian J. DEBOSCH, Cassandra HIGGINS, Yiming ZHANG, Allyson MAYER